the aid library

LIST OPTIONS

Filter

7240

Malaria Threat Map

World Health Organisation (WHO) (2025) C_WHO

The WHO Malaria Threats Map is an interactive online platform that showcases the latest global data on four critical biological threats to effective malaria control and elimination: mosquito insecticide resistance, Plasmodium falciparum hrp2/3 gene deletions, antimalarial drug resistance, and the ... more

External Link

External Link (340)

Malaria Consortium - Disease control, better health

Malaria Consortium (2025) C2

The Malaria Consortium website provides comprehensive information about the organization’s work in preventing, controlling, and eventually eliminating malaria and other communicable diseases. It showcases the organization’s projects, research, publications, and policy work across Africa and Asia... more

Download (179)

View PDF (121)

Plan stratégique national de lutte contre le paludisme 2023-2026

Programme National de Lutte contre le Paludisme (PNLP), Ministère de la Santé et de l’Hygiène Publique du Togo République Togolaise, Ministère de la Santé et de l’Hygiène Publique (2023) C2

Le Plan Stratégique National de Lutte contre le Paludisme 2023–2026 du Togo définit les grandes orientations pour réduire de 65 % l’incidence et la mortalité liées au paludisme d’ici 2026, en comparaison avec les niveaux de 2022. Élaboré par le Programme National de Lutte contre le Pa... more

Download (151)

View PDF (147)

National Strategic Plan for Malaria Elimination in Bangladesh: 2021-2025

National Malaria Elimination Programme - Directorate General of Health Services Ministry of Health & Family Welfare - Government of Bangladesh (2021) C2

The National Strategic Plan for Malaria Elimination 2021–2025 outlines Bangladesh’s roadmap to achieve zero indigenous malaria cases by 2030, with an interim goal to reduce transmission to near-zero levels by 2025. The strategy builds upon earlier successes in malaria control and shifts focus to... more

Download (171)

View PDF (169)

Malaria Strategic Plan 2021-2025 - Ghana

National Malaria Control Programme Ghana Health Service (2021) C2

The Ghana National Malaria Strategic Plan 2021–2025 aims to reduce malaria mortality by 90% and malaria cases by 50% (using 2019 as baseline) and to achieve pre-elimination in at least six districts by 2025. The plan focuses on scaling up prevention measures like distributing insecticide-treated n... more

Download (184)

View PDF (257)

National Malaria Elimination Strategic Plan (NMESP) 2024–2028

National Malaria Elimination Programme (NMEP) Ghana Health Service - Ministry of Health, Ghana (2023) C2

The National Malaria Elimination Strategic Plan (NMESP) 2024–2028 of Ghana outlines the country’s roadmap to shift from malaria control to elimination. Despite major progress—like reducing malaria deaths from nearly 2,800 in 2012 to 151 in 2022—malaria remains a major public health challenge... more

Download (178)

View PDF (145)

Plan Stratégique National de Lutte contre le Paludisme 2021–2027

Programme National de Lutte contre le Paludisme (PNLP), République du Burundi Ministère de la Santé Publique et de la Lutte contre le Sida, République du Burundi (2021) C2

Le Plan Stratégique National de Lutte contre le Paludisme 2021–2027 du Burundi expose la vision d’un Burundi sans décès lié au paludisme d’ici 2027. Le programme vise à réduire de 60 % la morbidité et à atteindre zéro mortalité grâce à une couverture universelle en prévention (m... more

Download (171)

View PDF (148)

Plan Stratégique National de Lutte contre le Paludisme au Sénégal 2021–2025

Programme National de Lutte contre le Paludisme (PNLP), Sénégal Ministère de la Santé et de l’Action Sociale, République du Sénégal (2020) C2

Le Plan Stratégique National de Lutte contre le Paludisme au Sénégal 2021–2025 a pour objectif de réduire l’incidence et la mortalité liées au paludisme d’au moins 75 % par rapport à 2019 et d’interrompre la transmission locale dans au moins 80 % des districts éligibles. Il repos... more

Download (237)

View PDF (138)

Plan Stratégique National de Lutte contre le Paludisme au Cameroun 2019–2023

Programme National de Lutte contre le Paludisme (PNLP), Cameroun Ministère de la Santé Publique, République du Cameroun (2019) C2

Le Plan Stratégique National de Lutte contre le Paludisme au Cameroun 2019–2023 vise à réduire l’incidence et la mortalité liées au paludisme dans tout le pays, en mettant l’accent sur les groupes les plus vulnérables comme les enfants de moins de 5 ans et les femmes enceintes. Il repose... more

Download (151)

View PDF (146)

Rwanda Malaria Strategic Plan 2020–2024

Ministry of Health, Rwanda; Rwanda Biomedical Centre (RBC) Ministry of Health, Republic of Rwanda (2020) C2

The Rwanda Malaria Strategic Plan 2020–2024 outlines Rwanda’s national strategy to reduce malaria morbidity and mortality by at least 50% compared to 2019 levels. The vision is a malaria-free Rwanda contributing to socioeconomic development. The plan includes strengthening prevention through lo... more

Download (190)

View PDF (171)

Plan d’action régional pour la vaccination dans les Amériques 2030

Pan American Health Organization PAHO; World Health Organization WHO (2025) CC

Le Plan d'action régional pour la vaccination dans les Amériques (RIAP) constitue une étape fondamentale pour consolider les progrès accomplis et offre une vision concrète pour relever les défis actuels et futurs en vue d'atteindre les objectifs fixés pour l'année 2030. Ce plan est essentiel... more

External Link

External Link (97)

Coinfection of COVID-19 and malaria: clinical profiles, interactions, and strategies for effective control

He, M.; Zhang, H.; Yang, Y. et al. (2025) C2

The emergence of SARS-CoV-2 has significantly altered the epidemiology of other infectious diseases, making investigations into its co-infection with malaria particularly relevant in endemic regions. This review examines the epidemiological, incubation and clinical features of the two diseases, high... more

External Link

External Link (77)

CDC Yellow Book

United Nations Centers for Disease Control and Preventenion (2025) C_CDC

The CDC Yellow Book is the Centers for Disease Control and Prevention's comprehensive reference guide to health issues related to international travel. It provides evidence-based recommendations and practical guidance for healthcare professionals advising travellers, as well as for travellers themse... more

External Link (109)

ANTIMICROBIAL RESISTANCE (AMR) AND MALARIA

World Health Organization WHO (2024) C_WHO

Antimicrobial resistance (AMR) and malaria remain significant public health challenges in the WHO Eastern Mediterranean Region (EMR). In 2021, the region reported 1.7 million sepsis-related deaths, with 373,000 associated with bacterial AMR. High antibiotic consumption, particularly in high-income c... more

Download (55)

View PDF (48)

Situation and Response Analysis Report on Malaria in the SADC Region

Directorate of Social & Human Development & Special Programs SADC Secretariat (2025) C2

Malaria remains a significant public health concern in the SADC region, accounting for 20% of childhood deaths, as well as prompting numerous outpatient visits and hospitalisations. Around three-quarters of the population, including 35 million children under the age of five and 8.5 million pregnant ... more

Download (67)

View PDF (57)

Best Buys to Accelerate Disease Elimination in the Americas

Pan American Health Organization PAHO (2025) C_WHO

The Best Buys for Disease Elimination is a practical, evidence-based guide to the most effective actions for countries to implement in order to eliminate communicable diseases. The guide highlights the efficient use of resources and prioritizing populations in vulnerable situations. “The Region... more

Download (405)

View PDF (499)

Practical manual on tuberculosis laboratory strengthening, 2022 update

World Health Organisation (WHO) (2023) C_WHO

The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la... more

Download (586)

View PDF (511)

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ...socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives more

Epidemiology of type 2 diabetes in India

Pradeepa, R.; Mohan, V. Indian Journal of Ophthalmology 69(11):p 2932-2938, November 2021. (2021) CC2

The burden of diabetes is high and increasing globally, and in developing economies like India, mainly fueled by the increasing prevalence of overweight/obesity and unhealthy lifestyles. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over... more

External Link

Chagas (maladie de, trypanosomiase américaine)

World Health Organization WHO (2022) C_WHO

Principaux faits D’après les estimations, 6 à 7 millions de personnes dans le monde sont infectées par Trypanosoma cruzi (T. Cruzi), le parasite responsable de la maladie de Chagas. La plupart de ces personnes vivent en Amérique latine. La transmission à l’être humain se fait principalem...ent, en Amérique latine, par l’intermédiaire d’un insecte appelé triatome, qui peut être porteur de T. cruzi. Parmi les autres modes de transmission de la maladie de Chagas, figurent : la transmission orale (par voie alimentaire), la transfusion de sang ou de produits sanguins, la transmission mère-enfant (congénitale), la transplantation d’organes et les accidents de laboratoire. La maladie de Chagas ne touchait auparavant que des zones rurales de la Région des Amériques, et surtout de l’Amérique latine. Ces dernières décennies, toutefois, les mouvements de population ont fait que la plupart des personnes infectées sont des habitants de zones urbaines (urbanisation) et que la maladie s’est propagée à d’autres continents (où T. cruzi se transmet par des voies non vectorielles). L’infection à T. cruzi est curable si un traitement est instauré rapidement après l’infection. Chez les personnes infectées de façon chronique, un traitement antiparasitaire peut éventuellement prévenir ou enrayer la progression de la maladie, et éviter sa transmission, notamment de la mère à l’enfant. Jusqu’à 30 % des personnes infectées de façon chronique présentent des troubles cardiaques, et jusqu’à 10 % d’entre elles souffrent de troubles digestifs et/ou neurologiques, ce qui peut imposer un traitement particulier. Les principales méthodes de prévention de la maladie de Chagas en Amérique latine sont la lutte antivectorielle ainsi que d’autres stratégies visant à réduire la transmission vectorielle. Dans le monde entier, le dépistage sanguin joue un rôle crucial dans la prévention de l’infection par transfusion ou transplantation d’organes. Il est essentiel de détecter et de traiter l’infection chez les femmes et les filles en âge de procréer, ainsi que de soumettre tout nouveau-né et ses frères et sœurs à un dépistage dans le cas où la mère est infectée et n’a jamais reçu de traitement antiparasitaire. Certains facteurs socio-économiques et environnementaux influent fortement sur la maladie de Chagas, dont la propagation et les différentes dimensions interdépendantes justifient la nécessité de mettre en œuvre des stratégies de lutte multisectorielles. Quelques pays ont mis en place la notification et la surveillance des cas aigus et chroniques et des voies de transmission actives, qui sont essentielles à la lutte contre la maladie de Chagas. more